European Journal of Medicinal Chemistry p. 277 - 289 (2019)
Update date:2022-08-11
Topics:
Maurya, Shiv S.
Bahuguna, Aparna
Khan, Shabana I.
Kumar, Deepak
Kholiya, Rohit
Rawat, Diwan S.
A series of novel molecular hybrids based on 4-aminoquinoline-pyrimidine were synthesized and examined for their antimalarial activity. Most of the compounds were found to have potent in vitro antimalarial activity against both CQ-sensitive D6 and CQ-resistant W2 strains of P. falciparum. The active compounds have no considerable cytotoxicity against the mammalian VERO cell lines. Twenty three compounds displayed better antimalarial activity against CQ-resistant strain W2 with IC50 values in the range 0.0189–0.945 μM, when compared with standard drug chloroquine. The best active compound 7d was studied for heme binding so as to find the primary mode of action of these hybrid molecules. Compound 7d was found to form a stable 1:1 complex with hematin as determined by its Job's plot which suggests that heme may be a probable target of these molecules. Docking studies performed with Pf-DHFR exhibited good binding interactions in the active site. The pharmacokinetic properties of some active compounds were also analysed using ADMET prediction.
View MoreBeijing Mashi Fine Chemical Co.,Ltd.
Contact:+86-10-61271592
Address:Room 506, Section B, Kaichi Mansion, Industrial Development
Contact:+86-0592 5353131
Address:No.56 Guani Road Software Park 2,Siming District
shandong lukang animal & plant drug trading co.,ltd.
Contact:15853765968
Address:floor 9, lukang ,jingying building,#173,taibai building west road,jining city,shandong,china
Hebei Fulong Import & Export Co., Ltd.
Contact:86-311-87795661
Address:15A19 Zhongyuan Building,368 Youyi North Street,Shijiazhuang 050070,China
Suzhou Kangrun Pharmaceutical, Inc
Contact:86-512-63912376,63913329
Address:Building 2, No. 2358 ,Chang'an Rd, Wujiang Economic Development Zone Pioneering park, china
Doi:10.1016/0022-1902(60)80101-7
(1960)Doi:10.1002/ejoc.201900277
(2019)Doi:10.1021/jo00162a013
(1983)Doi:10.1016/S0040-4039(00)71674-1
(1965)Doi:10.1016/S0957-4166(03)00326-4
(2003)Doi:10.1016/S0040-4039(98)01212-X
(1998)